Robuta

https://www.techtransfer.nih.gov/patent/e-047-2022-0-ae-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses | Technology Transfer human monoclonal antibodiesbroadlytargetcoronavirusestechnology https://www.techtransfer.nih.gov/patent/e-014-2017-0-fr-01 HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF | Technology Transfer human monoclonal antibodiesspecific https://www.techtransfer.nih.gov/patent/e-004-2005-4-au-06 Human Monoclonal Antibodies Against Hendra And Nipah | Technology Transfer human monoclonal antibodieshendranipahtechnologytransfer https://www.techtransfer.nih.gov/patent/e-251-2004-0-ca-04 Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies | Technology Transfer human monoclonal antibodiesbroadlycrossreactivehiv https://www.techtransfer.nih.gov/patent/e-047-2022-0-om-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses | Technology Transfer human monoclonal antibodiesbroadlytargetcoronavirusestechnology https://www.techtransfer.nih.gov/patent/e-217-2005-1-us-01 Human Monoclonal Antibodies That Specifically Bind IGF-II | Technology Transfer human monoclonal antibodiesspecificallybindigfii https://www.techtransfer.nih.gov/patent/e-162-2014-0-it-24 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE | Technology Transfer human monoclonal antibodiesusetechnologytransfer https://www.techtransfer.nih.gov/patent/e-014-2017-0-gb-01 HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF | Technology Transfer human monoclonal antibodiesspecific https://www.techtransfer.nih.gov/patent/e-004-2005-4-us-07 Human Monoclonal Antibodies Against Hendra And Nipah | Technology Transfer human monoclonal antibodieshendranipahtechnologytransfer https://www.techtransfer.nih.gov/patent/e-130-2011-0-fr-18 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof | Technology Transfer human monoclonal antibodies https://scholars.duke.edu/publication/744335 Scholars@Duke publication: Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified... human monoclonal antibodies https://www.techtransfer.nih.gov/patent/e-130-2011-0-pct-02 Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof | Technology Transfer human monoclonal antibodies https://pubchem.ncbi.nlm.nih.gov/patent/EP-0105804-B1 Human monoclonal antibodies against bacterial toxins - Patent EP-0105804-B1 - PubChem EP-0105804-B1 chemical patent summary. human monoclonal antibodiesbacterial toxins https://www.techtransfer.nih.gov/patent/e-438-1986-0-us-01 PREPARATION OF HUMAN MONOCLONAL ANTIBODIES OF SELECTIED SPECIFICITY AND ISOTYPES | Technology... human monoclonal antibodiespreparationspecificityisotypestechnology https://www.techtransfer.nih.gov/patent/e-004-2005-0-us-01 Human Monoclonal Antibodies Against Hendra And Hipah Viruses | Technology Transfer human monoclonal antibodieshendravirusestechnologytransfer https://www.techtransfer.nih.gov/patent/e-004-2005-1-us-01 Human Monoclonal Antibodies Against Hendra And Hipah. | Technology Transfer human monoclonal antibodieshendratechnologytransfer https://pubmed.ncbi.nlm.nih.gov/41087744/ Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx... Highly pathogenic avian influenza H5Nx viruses are an emerging threat for global health, especially clade 2.3.4.4b H5N1 virus which causes panzootic... human monoclonal antibodiescrossneutralizingpotent https://www.techtransfer.nih.gov/patent/e-162-2014-0-ch-11 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE | Technology Transfer human monoclonal antibodiesusetechnologytransfer https://pubmed.ncbi.nlm.nih.gov/33804519/ Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently... Australian bat lyssavirus (ABLV) is a rhabdovirus that circulates in four species of pteropid bats (ABLVp) and the yellow-bellied sheath-tailed bat (ABLVs) in... human monoclonal antibodiesisolationcharacterizationcross https://pubchem.ncbi.nlm.nih.gov/patent/EP-0672120-B1 Production of human monoclonal antibodies active against hepatitis b surface antigen - Patent... EP-0672120-B1 chemical patent summary. hepatitis b surface antigenhuman monoclonal antibodies https://www.techtransfer.nih.gov/patent/e-030-2021-0-pct-02 HUMAN MONOCLONAL ANTIBODIES TARGETING SARS-COV-2 | Technology Transfer human monoclonal antibodiessars covtargetingtechnologytransfer https://www.techtransfer.nih.gov/patent/e-004-2005-4-pct-01 Human Monoclonal Antibodies Against Hendra And Nipah | Technology Transfer human monoclonal antibodieshendranipahtechnologytransfer https://www.techtransfer.nih.gov/patent/e-047-2022-0-my-01 Human Monoclonal Antibodies That Broadly Target Coronaviruses | Technology Transfer human monoclonal antibodiesbroadlytargetcoronavirusestechnology https://www.techtransfer.nih.gov/patent/e-162-2014-0-jp-05 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE | Technology Transfer human monoclonal antibodiesusetechnologytransfer https://www.techtransfer.nih.gov/patent/e-217-2005-2-au-02 Human Monoclonal Antibodies That Specifically Bind IGF-II. | Technology Transfer human monoclonal antibodiesspecificallybindigfii https://pmc.ncbi.nlm.nih.gov/articles/PMC18751/ Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of... Promoting remyelination, a major goal of an effective treatment for demyelinating diseases, has the potential to protect vulnerable axons, increase conduction... human monoclonal antibodies https://www.techtransfer.nih.gov/patent/e-162-2014-0-nl-25 HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE | Technology Transfer human monoclonal antibodiesusetechnologytransfer https://www.techtransfer.nih.gov/patent/e-014-2017-0-us-01 Human Monoclonal Antibodies Against FLT3 and Uses Thereof | Technology Transfer human monoclonal antibodiesusestechnologytransfer https://cvvr.hms.harvard.edu/publication/cross-neutralizing-activity-of-human-anti-v3-monoclonal-antibodies-derived-from-non-clade-b-hiv-1-infected-individuals/ Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-clade B HIV-1... https://pmc.ncbi.nlm.nih.gov/articles/PMC7873987/ Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications... We sought to determine whether immune reactivity occurs between anti-SARS-CoV-2 protein antibodies and human tissue antigens, and whether molecular mimicry... https://www.techtransfer.nih.gov/patent/e-144-2002-1-us-01 Identification of Novel Broadly Cross-Reactive HIV 1 Neutralizing Human Monoclonal Antibodies |...